AFRIN ORIGINAL OTC
Generic Name and Formulations:
Oxymetazoline HCl 0.05%; nasal spray.
Merck & Co., Inc.
Indications for AFRIN ORIGINAL:
Adults and Children:
<6yrs: individualize. ≥6yrs: 2–3 sprays in each nostril not more than every 10–12 hours. Max 2 doses/day.
Use >3 days; may worsen nasal congestion.
Heart disease. Hypertension. Thyroid disease. Diabetes. Urinary retention. Enlarged prostate. Pregnancy. Nursing mothers.
Local effects (eg, burning, stinging, sneezing, increased nasal discharge).
Original nasal spray—30mL; No Drip Original, Severe Congestion, Extra Moisturizing, Sinus—15mL
Clinical Pain Advisor Articles
- Risks Associated With Co-Administration of Aspirin and Other NSAIDs
- Stages of Low Back Pain Have Specific Sets of Clinical Indicators
- FDA Approves Aimovig for Migraine Prevention
- First Non-Opioid Drug Approved for Managing Opioid Withdrawal Symptoms
- Pain Interference Associated With Depression, Pain Self-Efficacy in Chronic Musculoskeletal Pain
- Effect of Prescription Drug Monitoring Programs on Fatal, Nonfatal Drug Overdoses
- Standardized SCS Workflow May Effectively Alleviate Failed Back Surgery Syndrome-Related Pain
- Marijuana Legalization and Opioid Prescribing Rates
- Medical Marijuana Users More Likely to Use Prescription Drugs for Medical, Nonmedical Purposes
- Interbrain Coupling During Handholding Associated With Analgesia, Empathy
- Opioid-Related Adverse Drug Events Associated With Worse Patient, Cost Outcomes
- Education Plus Exercise, Single Corticosteroid Injection Effective in Long Term for Gluteal Tendinopathy
- Detox vs Medication-Assisted Treatment for Opioid Use Disorder in Pregnancy: Expert Roundtable
- Naloxone Training Beneficial for PA Students
- Supervised Injection Sites Hailed as the Latest Strategy to Fight the Opioid Crisis